FDA Oks Marketing Of First In Vitro Diagnostic Test To Detect Alzheimer's Disease

WASHINGTON (dpa-AFX) - The U.S. Food and Drug Administration or FDA granted marketing authorization for the first in vitro diagnostic test for early detection of amyloid plaques associated with

Related Keywords

United States ,Washington ,Americans ,Kostenloser Wertpapierhandel ,Alzheimer Disease Neuroimaging Initiative ,National Institutes Of Health ,Drug Administration ,Fujirebio Diagnostics Inc ,Amyloid Ratio ,Fujirebio Diagnostics ,Disease Neuroimaging Initiative ,National Institutes ,Marketing ,First ,Itro ,Iagnostic ,Pest ,Etect ,Lzheimer ,Disease ,